Skip to main content
Premium Trial:

Request an Annual Quote

EU Awards Consortium $3.6M to Study Genetic Basis of Breast, Prostate Cancer

NEW YORK, Dec. 19 (GenomeWeb News) - The European Union has awarded Polygene, a research consortium led by Iceland Genomics, a 3 million ($3.6 million) grant to study the inherited risk of breast and prostate cancer, the company said today.


The consortium will study 6,000 patients and controls to discover new genetic causes of breast and prostate cancer, making it one of the largest cancer genetics studies performed to date.


The consortium includes Iceland Genomics, Bioinformatics ApS of Denmark, the Department of Statistics at the University of Oxford, UK, and the Radboud University Nijmegen Medical Center of the Netherlands.


The results of the project are expected by the end of 2008.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.